Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Dancey JE, Dobbin KK, Groshen S, Jessup JM, Hruszkewycz AH, Koehler M, Parchment R, Ratain MJ, Shankar LK, Stadler WM, True LD, Gravell A, Grever MR; Biomarkers Task Force of the NCI Investigational Drug Steering Committee. Dancey JE, et al. Among authors: gravell a. Clin Cancer Res. 2010 Mar 15;16(6):1745-55. doi: 10.1158/1078-0432.CCR-09-2167. Epub 2010 Mar 9. Clin Cancer Res. 2010. PMID: 20215558
Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN).
Massett HA, Mishkin G, Moscow JA, Gravell A, Steketee M, Kruhm M, Han SH, Barry B, Montello M, Zwiebel J, Abrams JS, Doroshow JH, Ivy SP. Massett HA, et al. Among authors: gravell a. Clin Cancer Res. 2019 Dec 1;25(23):6925-6931. doi: 10.1158/1078-0432.CCR-19-1754. Epub 2019 Aug 22. Clin Cancer Res. 2019. PMID: 31439585 Free PMC article.
Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials.
Paller CJ, Huang EP, Luechtefeld T, Massett HA, Williams CC, Zhao J, Gravell AE, Tamashiro T, Reeves SA, Rosner GL, Carducci MA, Rubinstein L, Ivy SP. Paller CJ, et al. Among authors: gravell ae. Front Med (Lausanne). 2019 Jun 4;6:122. doi: 10.3389/fmed.2019.00122. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31214592 Free PMC article.
Clinical trials referral resource. ST1571.
Murgo A, Wood KF, Gravell AE, Cheson BD. Murgo A, et al. Among authors: gravell ae. Oncology (Williston Park). 2001 Jul;15(7):881-2, 885-6. Oncology (Williston Park). 2001. PMID: 11499689 No abstract available.
The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management.
Girotra M, Hansen A, Farooki A, Byun DJ, Min L, Creelan BC, Callahan MK, Atkins MB, Sharon E, Antonia SJ, West P, Gravell AE; Investigational Drug Steering Committee (IDSC) Immunotherapy Task Force collaboration. Girotra M, et al. Among authors: gravell ae. JNCI Cancer Spectr. 2018 Jul;2(3):pky021. doi: 10.1093/jncics/pky021. Epub 2018 Jul 19. JNCI Cancer Spectr. 2018. PMID: 30057972 Free PMC article. Review.
Clinical trials referral resource.
Wright JJ, Zerivitz K, Gravell A. Wright JJ, et al. Among authors: gravell a. Oncology (Williston Park). 2005 May;19(6):722, 725-6, 728 passim. Oncology (Williston Park). 2005. PMID: 15971449 No abstract available.
32 results